Quality Culture in Transfusion Medicine | Chapter 3 | New Visions in Medicine and Medical Science Vol. 1

The field of Transfusion Medicine as a bridging science, integrally deals with that part of the health care system that undertakes the appropriate provision and use of human blood resources, whether whole blood, plasma, or cellular components. The development of a safe blood supply and transfusion brings along the introduction of managing quality as a culture. This is implemented through the introduction of a quality system (QS) and a related quality management system (QMS). Quality system management (QSM) in transfusion medicine is about providing and assuring vein-to-vein safe and effective hemotherapy. In many situations in the world the idea is that when instructions are written (SOPs) a quality system is in place; one just has to follow the instructions and ‘that is it, we’re done’!

However, quality does not only partly depend on following instructions at the operational level. What is generally not understood is the importance of designing and implementing quality system management as an institutional culture, based on five key elements 1) organization and (infra)structure; 2) standards (technical and quality); 3) documentation to allow traceability and evidence; 4) education through continued teaching and training; 5) assessment through continued monitoring and evaluation. There are a number of quality management systems available, which can be applied to procurement and clinical use of blood. Some are “process”- and “operations-oriented” while others deal more with the management aspects, securing a quality environment and culture, necessary for consistency and reliability of the operational processes. The EU EFQM and Canadian ISQua systems are based on concepts of excellence.

To achieve an optimal understanding of the values of vein-to-vein quality in transfusion medicine, a culture has to be developed through ownership, stewardship, and commitment to and implementation of the principles of fitness for purpose, the supplier-producer-customer continuum, and customer-orientation and satisfaction. Commitment from top management is the driving force for a culture of quality. Leaders need to be clearly visible, engaged and unwavering in their support for quality improvement.

 

Author(s) Details:

Cees Th. Smit Sibinga,
IQM Consulting and University of Groningen, Netherlands.

Please see the link here: https://stm.bookpi.org/NVMMS-V1/article/view/13650

Hemovigilance Today – The Facts and the Fictions | Chapter 7 | Research Aspects in Biological Science Vol. 8

 Monitoring hazards from "vein-to-vein," or from the blood maker and collector to the bedside transfusion and back, is necessary for total quality management in blood collection and transfusion. As a tool for overall quality management assessment, hemovigilance is a collection of surveillance techniques that span the full transfusion chain, from the follow-up of recipients of transfusions to the supply of blood and its components. Hemovigilance was first practised in France in 1994 and Japan in 1993, and it has since spread to numerous other nations. A national ministry of health oversees some of these systems, while others are primarily run by professional associations or the nation's blood system. The dissemination of data to all parties involved should be the major goal. percentage of S. mortality After therapy was administered for 24, 48, and 72 hours, frugiperda larvae were seen in glasshouse conditions. The results showed that, in terms of insect mortality, the tested acetogenins significantly (P 0.05) varied from the untreated control. The combination of two natural products, rolliniastatin-2 (5) (100 g/mL) + squamocin (6) (100 g/mL) + LC (50 g/mL), which proved to be the most effective and gave (100%), produced the highest percent mortalities after 72 hours of treatment application, while rolliniastatin-2 (5) at 100 g/mL alone produced the lowest percent mortality (65%), followed by squamocin The mortality rate (25–35%) from the acetylated and methoxy methylated ACG compounds was quite low. The combination of elements is advised for integrated pest management. According to the findings, the commercial product's insecticidal effectiveness is enhanced by the addition of natural ACGs. A good hemovigilance system should comprise data collection (including both numerators and denominators), data analysis by experts, the creation of practice-improving recommendations, communication back to the front line, and education. Definitions must be precise, and each reported case must be thoroughly examined by professionals. A number of existing systems have shown how hemovigilance data can help patients have better results. Monitoring intervention results is essential for enhancing safety. Donor systems can also help to lessen mistakes and mishaps throughout the donation procedure. In reality, wherever transfusion medicine is practised, hemovigilance should be a fundamental component of the system. It should also be broadened to encompass biovigilance for other human-origin substances such cells, tissues, and organs. It is a myth to think that hemovigilance is only the simple registration of negative transfusion effects in the absence of a developed quality system and related quality system management.

Author(s) Details:

Cees Th. Smit Sibinga,
IQM Consulting and University of Groningen, Groningen, The Netherlands.

Please see the link here: https://stm.bookpi.org/RABS-V8/article/view/8196